Latest Headlines

Latest Headlines

Quidel gains CE mark for herpes/chicken pox molecular Dx

Quidel has its latest molecular diagnostic test approval in hand, this time a CE mark for a blood test that screens for herpes plus a virus that causes chicken pox and shingles.

IntelligentMDx wins CE mark for new herpes test

Massachusetts' IntelligentMDx is once again turning to Europe to debut a new diagnostics test.

Nanoparticles could help block herpes infection

Researchers at Johns Hopkins University say they've developed mucous-penetrating nanoparticles that can get anti-herpes drugs into the vaginal walls and help prevent infection.

Genocea's HSV-2 vax to hit the clinic

There is no preventive vaccine or cure, but Genocea Biosciences has a prophylactic HSV-2 vaccine moving into a first in-human clinical trial in third quarter 2012, Chip Clark, president and CEO told FierceVaccines at BIO 2012. Seth Hetherington, CMO, was also at the meeting, presenting in the session "Therapeutic Vaccines Against Chronic Infectious Diseases: Vaccines versus Microbes Part 2."

Coridon HSV-2 vaccine shows 100% efficacy

Brisbane, Australia-based biotech Coridon has developed a DNA vaccine for herpes simplex virus 2 that showed 100% efficacy in a preclinical trial. Thanks to financial backing from Allied Healthcare